The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Infectious Disease Biomarker Testing Market Research Report 2025
Synopsis
The global Infectious Disease Biomarker Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Infectious Disease Biomarker Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Infectious Disease Biomarker Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Infectious Disease Biomarker Testing in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Infectious Disease Biomarker Testing include Abacus Diagnostica, ALPCO, Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories and Danaher, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Biomarker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Biomarker Testing.
Report Scope
The Infectious Disease Biomarker Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Biomarker Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Biomarker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Hologic
PerkinElmer
Qiagen
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific
Segment by Type
PCR
NGS
ELISA or EIA
IHC
ISH
Others
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Academic Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Biomarker Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Infectious Disease Biomarker Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Infectious Disease Biomarker Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Infectious Disease Biomarker Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Infectious Disease Biomarker Testing in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Infectious Disease Biomarker Testing include Abacus Diagnostica, ALPCO, Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories and Danaher, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Biomarker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Biomarker Testing.
Report Scope
The Infectious Disease Biomarker Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Biomarker Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Biomarker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Hologic
PerkinElmer
Qiagen
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific
Segment by Type
PCR
NGS
ELISA or EIA
IHC
ISH
Others
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Academic Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Biomarker Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Biomarker Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 NGS
1.2.4 ELISA or EIA
1.2.5 IHC
1.2.6 ISH
1.2.7 Others
1.3 Market by Application
1.3.1 Global Infectious Disease Biomarker Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Academic Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Biomarker Testing Market Perspective (2019-2030)
2.2 Infectious Disease Biomarker Testing Growth Trends by Region
2.2.1 Global Infectious Disease Biomarker Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Disease Biomarker Testing Historic Market Size by Region (2019-2024)
2.2.3 Infectious Disease Biomarker Testing Forecasted Market Size by Region (2025-2030)
2.3 Infectious Disease Biomarker Testing Market Dynamics
2.3.1 Infectious Disease Biomarker Testing Industry Trends
2.3.2 Infectious Disease Biomarker Testing Market Drivers
2.3.3 Infectious Disease Biomarker Testing Market Challenges
2.3.4 Infectious Disease Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Biomarker Testing Players by Revenue
3.1.1 Global Top Infectious Disease Biomarker Testing Players by Revenue (2019-2024)
3.1.2 Global Infectious Disease Biomarker Testing Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Disease Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Biomarker Testing Revenue
3.4 Global Infectious Disease Biomarker Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Biomarker Testing Revenue in 2023
3.5 Infectious Disease Biomarker Testing Key Players Head office and Area Served
3.6 Key Players Infectious Disease Biomarker Testing Product Solution and Service
3.7 Date of Enter into Infectious Disease Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Biomarker Testing Breakdown Data by Type
4.1 Global Infectious Disease Biomarker Testing Historic Market Size by Type (2019-2024)
4.2 Global Infectious Disease Biomarker Testing Forecasted Market Size by Type (2025-2030)
5 Infectious Disease Biomarker Testing Breakdown Data by Application
5.1 Global Infectious Disease Biomarker Testing Historic Market Size by Application (2019-2024)
5.2 Global Infectious Disease Biomarker Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Disease Biomarker Testing Market Size (2019-2030)
6.2 North America Infectious Disease Biomarker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infectious Disease Biomarker Testing Market Size by Country (2019-2024)
6.4 North America Infectious Disease Biomarker Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Biomarker Testing Market Size (2019-2030)
7.2 Europe Infectious Disease Biomarker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infectious Disease Biomarker Testing Market Size by Country (2019-2024)
7.4 Europe Infectious Disease Biomarker Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Biomarker Testing Market Size (2019-2030)
8.2 Asia-Pacific Infectious Disease Biomarker Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Biomarker Testing Market Size (2019-2030)
9.2 Latin America Infectious Disease Biomarker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infectious Disease Biomarker Testing Market Size by Country (2019-2024)
9.4 Latin America Infectious Disease Biomarker Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Biomarker Testing Market Size (2019-2030)
10.2 Middle East & Africa Infectious Disease Biomarker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abacus Diagnostica
11.1.1 Abacus Diagnostica Company Detail
11.1.2 Abacus Diagnostica Business Overview
11.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Introduction
11.1.4 Abacus Diagnostica Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.1.5 Abacus Diagnostica Recent Development
11.2 ALPCO
11.2.1 ALPCO Company Detail
11.2.2 ALPCO Business Overview
11.2.3 ALPCO Infectious Disease Biomarker Testing Introduction
11.2.4 ALPCO Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.2.5 ALPCO Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Introduction
11.3.4 Abbott Laboratories Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Infectious Disease Biomarker Testing Introduction
11.4.4 Agilent Technologies Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.4.5 Agilent Technologies Recent Development
11.5 Becton
11.5.1 Becton Company Detail
11.5.2 Becton Business Overview
11.5.3 Becton Infectious Disease Biomarker Testing Introduction
11.5.4 Becton Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.5.5 Becton Recent Development
11.6 Dickinson and Company
11.6.1 Dickinson and Company Company Detail
11.6.2 Dickinson and Company Business Overview
11.6.3 Dickinson and Company Infectious Disease Biomarker Testing Introduction
11.6.4 Dickinson and Company Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.6.5 Dickinson and Company Recent Development
11.7 bioMérieux SA
11.7.1 bioMérieux SA Company Detail
11.7.2 bioMérieux SA Business Overview
11.7.3 bioMérieux SA Infectious Disease Biomarker Testing Introduction
11.7.4 bioMérieux SA Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.7.5 bioMérieux SA Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Detail
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Introduction
11.8.4 Bio-Rad Laboratories Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 Danaher
11.9.1 Danaher Company Detail
11.9.2 Danaher Business Overview
11.9.3 Danaher Infectious Disease Biomarker Testing Introduction
11.9.4 Danaher Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.9.5 Danaher Recent Development
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Detail
11.10.2 F. Hoffmann-La Roche Business Overview
11.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Introduction
11.10.4 F. Hoffmann-La Roche Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.10.5 F. Hoffmann-La Roche Recent Development
11.11 Hologic
11.11.1 Hologic Company Detail
11.11.2 Hologic Business Overview
11.11.3 Hologic Infectious Disease Biomarker Testing Introduction
11.11.4 Hologic Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.11.5 Hologic Recent Development
11.12 PerkinElmer
11.12.1 PerkinElmer Company Detail
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Infectious Disease Biomarker Testing Introduction
11.12.4 PerkinElmer Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.12.5 PerkinElmer Recent Development
11.13 Qiagen
11.13.1 Qiagen Company Detail
11.13.2 Qiagen Business Overview
11.13.3 Qiagen Infectious Disease Biomarker Testing Introduction
11.13.4 Qiagen Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.13.5 Qiagen Recent Development
11.14 Quest Diagnostics Incorporated
11.14.1 Quest Diagnostics Incorporated Company Detail
11.14.2 Quest Diagnostics Incorporated Business Overview
11.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Introduction
11.14.4 Quest Diagnostics Incorporated Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.14.5 Quest Diagnostics Incorporated Recent Development
11.15 Siemens Healthineers
11.15.1 Siemens Healthineers Company Detail
11.15.2 Siemens Healthineers Business Overview
11.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Introduction
11.15.4 Siemens Healthineers Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.15.5 Siemens Healthineers Recent Development
11.16 Thermo Fisher Scientific
11.16.1 Thermo Fisher Scientific Company Detail
11.16.2 Thermo Fisher Scientific Business Overview
11.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Introduction
11.16.4 Thermo Fisher Scientific Revenue in Infectious Disease Biomarker Testing Business (2019-2024)
11.16.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Infectious Disease Biomarker Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of PCR
Table 3. Key Players of NGS
Table 4. Key Players of ELISA or EIA
Table 5. Key Players of IHC
Table 6. Key Players of ISH
Table 7. Key Players of Others
Table 8. Global Infectious Disease Biomarker Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Infectious Disease Biomarker Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Infectious Disease Biomarker Testing Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Infectious Disease Biomarker Testing Market Share by Region (2019-2024)
Table 12. Global Infectious Disease Biomarker Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Infectious Disease Biomarker Testing Market Share by Region (2025-2030)
Table 14. Infectious Disease Biomarker Testing Market Trends
Table 15. Infectious Disease Biomarker Testing Market Drivers
Table 16. Infectious Disease Biomarker Testing Market Challenges
Table 17. Infectious Disease Biomarker Testing Market Restraints
Table 18. Global Infectious Disease Biomarker Testing Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Infectious Disease Biomarker Testing Market Share by Players (2019-2024)
Table 20. Global Top Infectious Disease Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Biomarker Testing as of 2023)
Table 21. Ranking of Global Top Infectious Disease Biomarker Testing Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Infectious Disease Biomarker Testing Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Infectious Disease Biomarker Testing Product Solution and Service
Table 25. Date of Enter into Infectious Disease Biomarker Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Infectious Disease Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Infectious Disease Biomarker Testing Revenue Market Share by Type (2019-2024)
Table 29. Global Infectious Disease Biomarker Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Infectious Disease Biomarker Testing Revenue Market Share by Type (2025-2030)
Table 31. Global Infectious Disease Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Infectious Disease Biomarker Testing Revenue Market Share by Application (2019-2024)
Table 33. Global Infectious Disease Biomarker Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Infectious Disease Biomarker Testing Revenue Market Share by Application (2025-2030)
Table 35. North America Infectious Disease Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Infectious Disease Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Infectious Disease Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Infectious Disease Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Infectious Disease Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Infectious Disease Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Infectious Disease Biomarker Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Infectious Disease Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Infectious Disease Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Infectious Disease Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Infectious Disease Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)
Table 50. Abacus Diagnostica Company Detail
Table 51. Abacus Diagnostica Business Overview
Table 52. Abacus Diagnostica Infectious Disease Biomarker Testing Product
Table 53. Abacus Diagnostica Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 54. Abacus Diagnostica Recent Development
Table 55. ALPCO Company Detail
Table 56. ALPCO Business Overview
Table 57. ALPCO Infectious Disease Biomarker Testing Product
Table 58. ALPCO Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 59. ALPCO Recent Development
Table 60. Abbott Laboratories Company Detail
Table 61. Abbott Laboratories Business Overview
Table 62. Abbott Laboratories Infectious Disease Biomarker Testing Product
Table 63. Abbott Laboratories Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 64. Abbott Laboratories Recent Development
Table 65. Agilent Technologies Company Detail
Table 66. Agilent Technologies Business Overview
Table 67. Agilent Technologies Infectious Disease Biomarker Testing Product
Table 68. Agilent Technologies Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 69. Agilent Technologies Recent Development
Table 70. Becton Company Detail
Table 71. Becton Business Overview
Table 72. Becton Infectious Disease Biomarker Testing Product
Table 73. Becton Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 74. Becton Recent Development
Table 75. Dickinson and Company Company Detail
Table 76. Dickinson and Company Business Overview
Table 77. Dickinson and Company Infectious Disease Biomarker Testing Product
Table 78. Dickinson and Company Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 79. Dickinson and Company Recent Development
Table 80. bioMérieux SA Company Detail
Table 81. bioMérieux SA Business Overview
Table 82. bioMérieux SA Infectious Disease Biomarker Testing Product
Table 83. bioMérieux SA Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 84. bioMérieux SA Recent Development
Table 85. Bio-Rad Laboratories Company Detail
Table 86. Bio-Rad Laboratories Business Overview
Table 87. Bio-Rad Laboratories Infectious Disease Biomarker Testing Product
Table 88. Bio-Rad Laboratories Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 89. Bio-Rad Laboratories Recent Development
Table 90. Danaher Company Detail
Table 91. Danaher Business Overview
Table 92. Danaher Infectious Disease Biomarker Testing Product
Table 93. Danaher Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 94. Danaher Recent Development
Table 95. F. Hoffmann-La Roche Company Detail
Table 96. F. Hoffmann-La Roche Business Overview
Table 97. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product
Table 98. F. Hoffmann-La Roche Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 99. F. Hoffmann-La Roche Recent Development
Table 100. Hologic Company Detail
Table 101. Hologic Business Overview
Table 102. Hologic Infectious Disease Biomarker Testing Product
Table 103. Hologic Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 104. Hologic Recent Development
Table 105. PerkinElmer Company Detail
Table 106. PerkinElmer Business Overview
Table 107. PerkinElmer Infectious Disease Biomarker Testing Product
Table 108. PerkinElmer Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 109. PerkinElmer Recent Development
Table 110. Qiagen Company Detail
Table 111. Qiagen Business Overview
Table 112. Qiagen Infectious Disease Biomarker Testing Product
Table 113. Qiagen Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 114. Qiagen Recent Development
Table 115. Quest Diagnostics Incorporated Company Detail
Table 116. Quest Diagnostics Incorporated Business Overview
Table 117. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product
Table 118. Quest Diagnostics Incorporated Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 119. Quest Diagnostics Incorporated Recent Development
Table 120. Siemens Healthineers Company Detail
Table 121. Siemens Healthineers Business Overview
Table 122. Siemens Healthineers Infectious Disease Biomarker Testing Product
Table 123. Siemens Healthineers Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 124. Siemens Healthineers Recent Development
Table 125. Thermo Fisher Scientific Company Detail
Table 126. Thermo Fisher Scientific Business Overview
Table 127. Thermo Fisher Scientific Infectious Disease Biomarker Testing Product
Table 128. Thermo Fisher Scientific Revenue in Infectious Disease Biomarker Testing Business (2019-2024) & (US$ Million)
Table 129. Thermo Fisher Scientific Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Biomarker Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Infectious Disease Biomarker Testing Market Share by Type: 2023 VS 2030
Figure 3. PCR Features
Figure 4. NGS Features
Figure 5. ELISA or EIA Features
Figure 6. IHC Features
Figure 7. ISH Features
Figure 8. Others Features
Figure 9. Global Infectious Disease Biomarker Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Infectious Disease Biomarker Testing Market Share by Application: 2023 VS 2030
Figure 11. Hospitals and Clinics Case Studies
Figure 12. Diagnostic Centers Case Studies
Figure 13. Academic Research Institutes Case Studies
Figure 14. Others Case Studies
Figure 15. Infectious Disease Biomarker Testing Report Years Considered
Figure 16. Global Infectious Disease Biomarker Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Infectious Disease Biomarker Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Infectious Disease Biomarker Testing Market Share by Region: 2023 VS 2030
Figure 19. Global Infectious Disease Biomarker Testing Market Share by Players in 2023
Figure 20. Global Top Infectious Disease Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Biomarker Testing as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Infectious Disease Biomarker Testing Revenue in 2023
Figure 22. North America Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Infectious Disease Biomarker Testing Market Share by Country (2019-2030)
Figure 24. United States Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Infectious Disease Biomarker Testing Market Share by Country (2019-2030)
Figure 28. Germany Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Infectious Disease Biomarker Testing Market Share by Region (2019-2030)
Figure 36. China Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Infectious Disease Biomarker Testing Market Share by Country (2019-2030)
Figure 44. Mexico Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Infectious Disease Biomarker Testing Market Share by Country (2019-2030)
Figure 48. Turkey Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Infectious Disease Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Abacus Diagnostica Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 51. ALPCO Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 52. Abbott Laboratories Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 53. Agilent Technologies Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 54. Becton Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 55. Dickinson and Company Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 56. bioMérieux SA Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 58. Danaher Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 60. Hologic Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 61. PerkinElmer Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 62. Qiagen Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 63. Quest Diagnostics Incorporated Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 64. Siemens Healthineers Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
